ANAPTYSBIO, INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $51.2m $81.2m $113.6m $171.0m $250.5m $495.7m $71.3m $36.0m $123.1m $238.2m
Prepaid Expense and Other Assets, Current $1.6m $2.7m $7.0m $3.5m $2.9m $4.9m $4.5m $9.1m $5.7m $4.8m
Assets, Current $58.2m $252.7m $434.2m $377.7m $396.6m $553.9m $447.2m $406.8m $431.9m $350.2m
Property, Plant and Equipment, Net $471k $665k $1.4m $1.6m $1.8m $2.3m $2.1m $2.1m $1.8m $1.4m
Operating Lease, Right-of-Use Asset $1.4m $344k $19.6m $17.9m $16.2m $14.4m $12.5m
Other Assets, Noncurrent $148k $1.5m $602k $256k $256k $256k $256k $256k
Accrued Liabilities, Current $3.4m $4.9m $8.8m $11.1m $15.3m $12.9m $21.6m $31.0m $39.5m $32.7m
Assets $62.2m $329.4m $509.0m $435.2m $416.6m $643.1m $610.4m $452.4m $483.8m $364.4m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $871k $342k $1.5m $1.6m $1.8m $1.9m $2.1m
Accounts Payable, Current $2.3m $2.3m $5.4m $16.2m $4.2m $1.7m $2.8m $4.7m $4.0m $3.9m
Operating Lease, Liability, Noncurrent $654k $0 $19.4m $17.8m $16.0m $14.1m $12.0m
Liabilities, Current $5.7m $14.1m $21.8m $29.5m $19.8m $16.1m $26.1m $37.4m $45.4m $38.6m
Other Liabilities, Noncurrent $654k $0
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $3k $24k $27k $27k $27k $28k $29k $27k $30k $28k
Additional Paid in Capital $16.7m $393.0m $633.3m $648.7m $660.7m $678.6m $717.8m $703.0m $829.9m $809.8m
Retained Earnings (Accumulated Deficit) ($54.9m) ($85.0m) ($146.7m) ($244.0m) ($264.0m) ($321.8m) ($450.5m) ($614.1m) ($759.3m) ($772.6m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 ($426k) ($223k) $338k ($4k) ($422k) ($5.2m) ($797k) $305k ($24k)
Stockholders' Equity Attributable to Parent ($38.2m) $307.6m $486.4m $405.0m $396.7m $356.4m $262.1m $88.1m $70.9m $37.2m
Liabilities and Equity $62.2m $329.4m $509.0m $435.2m $416.6m $643.1m $610.4m $452.4m $483.8m $364.4m